Finance

Lists
ELAN:NYSE
Elanco Animal Health Inc
US$ २३.८३
+१.२३%
(+०.२९) 1D
अक्टोबर १६, १०:०५:१४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELAN...
Open
US$ २३.८७
High
US$ २४.११
Low
US$ २३.७३
Mkt. cap
११.९१ अरब
Avg. vol.
५३.३८ लाख
Volume
१.८१ लाख
52-wk high
US$ २७.९८
52-wk low
US$ १९.४०
EPS
-US$ ०.४२
Beta
१.७१
Shares outstanding
४९.९६ करोड
No. of employees
१० हजार
Open
US$ २३.८७
High
US$ २४.११
Low
US$ २३.७३
Mkt. cap
११.९१ अरब
Avg. vol.
५३.३८ लाख
Volume
१.८१ लाख
52-wk high
US$ २७.९८
52-wk low
US$ १९.४०
EPS
-US$ ०.४२
Beta
१.७१
Shares outstanding
४९.९६ करोड
No. of employees
१० हजार
News stories
From web sources and news partners
Profile
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
About Elanco Animal Health Inc
CEOJeffrey N. Simmons
Employees९.६५ हजार
Founded१९५४
Headquartersइन्डियानापोलिस, इन्डियाना, संयुक्त राज्य अमेरिका
Sector-
Websiteelanco.com
Analyst ratings
Based on 12 analysts giving stock ratings to ELAN in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ELAN in the last 3 months.
Highest
Current US$ २३.८३
US$ ३४.०० (+४२.६८%)
Average
US$ ३१.६० (+३२.६१%)
Lowest
US$ २६.०० (+९.११%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chris Schott
J.P. Morgan
Buy
Maintained
US$ ३३.००
+३८.५%
10/16/2026
Daniel Clark
Leerink Partners
Buy
Reiterated
US$ ३४.००
+४२.७%
10/01/2026
Jonathan Block
Stifel Nicolaus
Buy
Reiterated
-
-
09/18/2026
Steve Scala
TD Cowen
Buy
Reiterated
US$ ३२.००
+३४.३%
08/25/2026
Glen Santangelo
Barclays
Buy
Maintained
US$ ३०.००
+२५.९%
08/21/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
US$ ३४.००
+४२.७%
08/12/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/12/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
US$ २६.००
+९.१%
08/10/2026
David Westenberg
Piper Sandler
Buy
Maintained
US$ ३०.००
+२५.९%
08/10/2026
Andrea Alfonso
UBS
Buy
Maintained
US$ ३३.००
+३८.५%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
US$ ३४.००
+४२.७%
08/06/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
US$ ३०.००
+२५.९%
08/06/2026
Jasper Hellweg
Argus Research
Buy
Maintained
-
-
06/23/2026
Umer Raffat
Evercore ISI
Buy
Maintained
-
-
05/11/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ ३०.००
+२५.९%
02/25/2026
Last report
२०२६ अगस्ट ५
Fiscal period
Q2 2026
US$ ०.३४ / US$ ०.२७
+२६.४६%beat
Revenue / Est. (USD)
१.३७ अरब / १.३१ अरब
+४.१६%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.१४ अरब
१.१४ अरब
१.३७ अरब
१.३७ अरब
Cost of goods sold
५३.०० करोड
५५.५० करोड
५८.६० करोड
५७.०० करोड
Cost of revenue
५३.०० करोड
५५.५० करोड
५८.६० करोड
५७.०० करोड
Research and development expenses
८.९० करोड
९.३० करोड
९.७० करोड
९.२० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३५.१० करोड
३३.१० करोड
३८.१० करोड
४४.९० करोड
Operating expense
५८.०० करोड
५६.३० करोड
६१.६० करोड
६८.०० करोड
Total operating expenses
१.११ अरब
१.१२ अरब
१.२० अरब
१.२५ अरब
Operating income
२.७० करोड
२.६० करोड
१६.९० करोड
११.८० करोड
Other non operating income
२०.०० लाख
-१.५० करोड
-८०.०० लाख
-१.१० करोड
EBT including unusual items
-५.०० करोड
-२५.९० करोड
८.७० करोड
५.६० करोड
EBT excluding unusual items
-२.५० करोड
-३.७० करोड
१०.३० करोड
६.५० करोड
Income tax expense
-१.६० करोड
१.७० करोड
३.०० करोड
२०.०० लाख
Effective tax rate
३२.००%
-६.५६%
३४.४८%
३.५७%
Other operating expenses
-
-
-
-
Net income
-३.४० करोड
-२७.६० करोड
५.७० करोड
५.४० करोड
Net profit margin
-२.९९%
-२४.१३%
४.१६%
३.९५%
Earnings per share
०.१९
०.१३
०.४०
०.३४
Interest and investment income
-
४.५० करोड
-
-
Interest expense
-५.२० करोड
-१०.५० करोड
-५.७० करोड
-५.९० करोड
Net interest expenses
-५.२० करोड
-६.०० करोड
-५.७० करोड
-५.९० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१९.५० करोड
१९.४० करोड
३३.५० करोड
२८.३० करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू